IQVIA Holdings, Inc.

IQV

$200.60

Name : IQVIA Holdings, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $34,102,001,664.00

EPSttm : 6.91

IQVIA Holdings, Inc.

$200.60

0.13%

$0.26

Float Short %

2.77

Margin Of Safety %

Put/Call OI Ratio

1.19

EPS Next Q Diff

1.85

EPS Last/This Y

4.29

EPS This/Next Y

Price

200.67

Target Price

216.53

Analyst Recom

1.54

Performance Q

21.19

Relative Volume

0.66

Beta

1.33

Ticker: IQV

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	IQV	187.68	1.20	1.07	15257
2025-09-09	IQV	189.68	1.20	1.13	15239
2025-09-10	IQV	183.78	1.20	24.49	15297
2025-09-11	IQV	190.53	1.39	1.89	16641
2025-09-12	IQV	187.26	1.38	1.04	16627
2025-09-15	IQV	185.99	1.38	0.18	16570
2025-09-16	IQV	186.72	1.36	0.85	16678
2025-09-17	IQV	186.69	1.3618616494554	0.53846153846154	16696
2025-09-18	IQV	190.15	1.36	0.36	16714
2025-09-19	IQV	187.27	1.35	0.17	16811
2025-09-22	IQV	187.8	1.32	0.17	14228
2025-09-23	IQV	186.47	1.24	0.95	14618
2025-09-24	IQV	181.16	1.23	0.43	14654
2025-09-25	IQV	176.57	1.23	0.85	14685
2025-09-26	IQV	179.56	1.24	1.53	14699
2025-09-29	IQV	180.73	1.23	0.86	14714
2025-09-30	IQV	190.01	1.23	0.81	14736
2025-10-01	IQV	203.9	1.23	0.25	14739
2025-10-02	IQV	204.48	1.19	1.04	15045
2025-10-03	IQV	206.48	1.19	0.23	15104
2025-10-06	IQV	205.03	1.17	1.14	15295
2025-10-07	IQV	200.78	1.17	3.50	15306
2025-10-08	IQV	200.61	1.19	2.35	15473
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	IQV	187.68	4.8	550.3	11.87
2025-09-09	IQV	189.68	4.8	570.7	11.87
2025-09-10	IQV	183.79	4.8	489.6	11.87
2025-09-11	IQV	190.69	4.8	621.8	11.87
2025-09-12	IQV	187.17	4.8	514.1	11.87
2025-09-15	IQV	185.99	4.8	537.1	11.87
2025-09-16	IQV	186.81	4.7	558.7	11.87
2025-09-17	IQV	186.72	4.7	549.0	11.87
2025-09-18	IQV	190.20	4.7	586.6	11.87
2025-09-19	IQV	187.22	4.7	519.3	11.86
2025-09-22	IQV	187.83	4.7	556.3	11.86
2025-09-23	IQV	186.51	4.7	536.3	11.86
2025-09-24	IQV	181.18	4.7	494.9	11.86
2025-09-25	IQV	176.69	4.7	501.5	11.86
2025-09-26	IQV	179.56	4.7	581.1	11.86
2025-09-29	IQV	180.77	4.7	562.9	11.86
2025-09-30	IQV	189.96	4.7	648.6	11.86
2025-10-01	IQV	203.85	4.7	693.3	11.86
2025-10-02	IQV	204.19	4.7	553.9	11.86
2025-10-03	IQV	206.56	4.7	571.7	11.86
2025-10-06	IQV	205.04	4.6	556.8	11.86
2025-10-07	IQV	200.83	4.6	509.1	11.86
2025-10-08	IQV	200.67	4.6	548.1	11.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	IQV	-0.43	5.16	3.39
2025-09-09	IQV	-0.43	5.16	3.39
2025-09-10	IQV	-0.43	5.16	3.39
2025-09-11	IQV	-0.43	5.16	2.93
2025-09-12	IQV	-0.43	5.16	2.93
2025-09-15	IQV	-0.43	5.14	2.93
2025-09-16	IQV	-0.43	5.14	2.93
2025-09-17	IQV	-0.43	5.14	2.93
2025-09-18	IQV	-0.43	5.14	2.93
2025-09-19	IQV	-0.43	5.14	2.93
2025-09-22	IQV	-0.43	5.15	2.93
2025-09-23	IQV	-0.43	5.15	2.93
2025-09-24	IQV	-0.43	5.15	2.93
2025-09-25	IQV	-0.43	5.15	2.77
2025-09-26	IQV	-0.43	5.15	2.77
2025-09-29	IQV	-0.43	5.12	2.77
2025-09-30	IQV	-0.43	5.12	2.77
2025-10-01	IQV	-0.43	5.12	2.77
2025-10-02	IQV	-0.43	5.12	2.77
2025-10-03	IQV	-0.43	5.12	2.77
2025-10-06	IQV	-0.43	5.07	2.77
2025-10-07	IQV	-0.43	5.07	2.77
2025-10-08	IQV	-0.43	5.07	2.77
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

1.54

Avg. EPS Est. Current Quarter

2.97

Avg. EPS Est. Next Quarter

3.39

Insider Transactions

-0.43

Institutional Transactions

5.07

Beta

1.33

Average Sales Estimate Current Quarter

4073

Average Sales Estimate Next Quarter

4233

Fair Value

215.87

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

29.7

Max Drawdown 5-Year %

-51.5

Target Price

216.53

P/E

29.06

Forward P/E

15.63

PEG

3.53

P/S

2.17

P/B

5.9

P/Free Cash Flow

16.97

EPS

6.9

Average EPS Est. Cur. Y

11.86

EPS Next Y. (Est.)

12.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.88

Relative Volume

0.66

Return on Equity vs Sector %

-3.8

Return on Equity vs Industry %

10.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

548.1

IQVIA Holdings, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 90000

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

stock quote shares IQV – IQVIA Holdings Inc. Stock Price stock today

news today IQV – IQVIA Holdings Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch IQV – IQVIA Holdings Inc. yahoo finance google finance

stock history IQV – IQVIA Holdings Inc. invest stock market

stock prices IQV premarket after hours

ticker IQV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: IQV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y